XML 69 R51.htm IDEA: XBRL DOCUMENT v3.20.4
Selected Quarterly Financial Data (Unaudited) (Tables)
 12 Months Ended
Dec. 31, 2020
Selected Quarterly Financial Data
The following table presents selected unaudited quarterly financial data for 2020 and 2019:
 
    
2020
  
    
4th quarter
 
 
3rd quarter
 
 
2nd quarter
 
 
1st quarter
  
    
U.S $ in millions (except per share amounts)
  
Net revenues
      4,454       3,978       3,870       4,357  
Gross profit
      2,048       1,852       1,763       2,063  
Net income (loss)
      162       (4,340 )      53       25  
Net income (loss) attributable to Teva
      150       (4,349 )      140       69  
Net income (loss) attributable to ordinary shareholders
      150       (4,349 )      140       69  
Earnings per share attributable to ordinary shareholders:
                                 
Basic
      0.14       (3.97 )      0.13       0.06  
Diluted
      0.14       (3.97 )      0.13       0.06  
   
    
2019
 
    
4th quarter
 
 
3rd quarter
 
 
2nd quarter
 
 
1st quarter
 
    
U.S $ in millions (except per share amounts)
  
Net revenues
      4,468       4,093       4,177       4,149  
Gross profit
      1,958       1,830       1,893       1,856  
Net income (loss)
      75       (307 )      (671 )      (97 ) 
Net income (loss) attributable to Teva
      110       (314 )      (689 )      (105 ) 
Net income (loss) attributable to ordinary shareholders
      110       (314 )      (689 )      (105 ) 
Earnings per share attributable to ordinary shareholders:
                                 
Basic
      0.10       (0.29 )      (0.63 )      (0.10 ) 
Diluted
      0.10       (0.29 )      (0.63 )      (0.10 )